Eastman Executive and Leadership Team

Mark Costa, the Chairman & Chief Executive Officer at Eastman, directs the overarching corporate strategy and long-term vision for the global specialty materials manufacturer. Overseeing the executive leadership team, the Chairman & Chief Executive Officer ensures alignment between innovative material development and market-driven growth objectives. This leadership role involves navigating complex international regulatory environments while expanding the footprint of advanced materials in the transportation and construction sectors. By prioritizing sustainable material solutions, Mark Costa drives the company toward operational excellence and enhanced shareholder value. The Chairman & Chief Executive Officer maintains rigorous oversight of capital allocation, ensuring that investments in specialty chemicals and functional products yield competitive advantages. Through consistent engagement with the Board, the Chairman & Chief Executive Officer secures the stability of the organization, fostering a culture of innovation that defines the current market position of the firm within the global chemical industry.

Jennifer Wang, the Finance Director, Global Business & 3b Revenue External Reporting Segment) Segment Chief Financial Officer at Eastman, manages the financial integrity and reporting accuracy for critical revenue segments. Overseeing complex fiscal analysis, the Finance Director, Global Business & 3b Revenue External Reporting Segment) Segment Chief Financial Officer ensures that financial disclosures meet stringent regulatory standards while providing actionable insights for business unit leaders. This leadership role involves evaluating the profitability of specialty materials and fibers, directly influencing strategic decisions regarding product portfolio expansion. By monitoring revenue streams across diverse industries, Wang supports the optimization of cost structures and capital efficiency. The Finance Director, Global Business & 3b Revenue External Reporting Segment) Segment Chief Financial Officer collaborates with cross-functional teams to forecast market trends, ensuring that financial planning remains responsive to global economic shifts. Jennifer Wang maintains rigorous control over segment-level financial performance, providing the transparency necessary for sustained investment in innovative material solutions.

William McLain, the Chief Financial Officer & Executive Vice President at Eastman, manages the global financial strategy, capital structure, and investor relations for the organization. Overseeing the fiscal health of the company, the Chief Financial Officer & Executive Vice President ensures that financial resources support the development of advanced materials and specialty chemicals. This leadership role involves executing large-scale financial initiatives that drive growth in the transportation and consumer goods sectors. By maintaining strong relationships with the investment community, McLain communicates the strategic value of the company's sustainable material solutions. The Chief Financial Officer & Executive Vice President directs the internal audit and risk management functions, ensuring compliance and operational stability across all geographic regions. William McLain provides the financial discipline required to navigate market volatility, ultimately securing the long-term financial viability of the firm while enabling continued investment in research and development for high-performance fibers and additives.

Erwin Dijkman, the President, Chemical Intermediates & Fibers Division at Eastman, directs the manufacturing and commercial operations for the core chemical and fiber product lines. Overseeing the production efficiency of these essential materials, the President, Chemical Intermediates & Fibers Division ensures that supply chains remain robust to meet the demands of the textile and industrial sectors. This leadership role involves optimizing manufacturing processes to enhance the quality and sustainability of chemical intermediates. By driving market expansion for fiber products, Dijkman secures the competitive position of the division within the global marketplace. The President, Chemical Intermediates & Fibers Division collaborates with sales and marketing teams to identify emerging opportunities for material applications, ensuring that production output aligns with customer requirements. Erwin Dijkman maintains a focus on operational excellence, implementing strategies that increase throughput and reduce costs, thereby supporting the overall profitability and growth objectives of the company's diverse material portfolio.

Aldo Noseda, the Chief Information Officer at Eastman, architects the digital infrastructure and technological framework supporting global manufacturing operations. Overseeing the integration of advanced data analytics, the Chief Information Officer ensures that digital systems optimize the production of specialty chemicals and additives. This leadership role involves modernizing enterprise resource planning to improve efficiency across the supply chain, directly impacting the delivery of functional products to healthcare and agriculture clients. By implementing robust cybersecurity protocols, Noseda protects the intellectual property and proprietary material research of the organization. The Chief Information Officer collaborates with operational leaders to deploy automation tools that streamline manufacturing processes, thereby reducing waste and increasing output. Aldo Noseda drives the digital transformation agenda, ensuring that technological capabilities remain aligned with the evolving needs of the specialty materials market, ultimately securing a scalable foundation for future growth and operational agility across all international business units.

Ibrahim Heiba, the Chief Medical Officer at Eastman, directs the health, safety, and regulatory compliance standards for materials utilized in healthcare and consumer applications. Overseeing the clinical evaluation of specialty chemicals, the Chief Medical Officer ensures that all products meet rigorous safety benchmarks for medical and agricultural use. This leadership role involves collaborating with research teams to validate the biocompatibility and safety profiles of new material innovations. By monitoring global health regulations, Heiba mitigates risks associated with product development and market entry. The Chief Medical Officer provides critical guidance on the intersection of material science and human health, ensuring that the company maintains its reputation for safety and reliability. Ibrahim Heiba drives the integration of medical expertise into the product lifecycle, ensuring that every specialty material produced adheres to the highest standards of safety, thereby protecting the brand and supporting the expansion of the company into sensitive healthcare markets.